Seeking a botanic extract for urinary health

Desired outcome

An European fast-growing and solid company is seeking an innovative botanic extracts with functional effects on the urinary functions in both genres. The successful offer will include 1) an innovative product with the highest level of evidence 2) ready to be used and marketed immediately 3) able to be included in food supplements, OTC or Pharma finished products. The extract would contain antimicrobial, antihyperplasia, urolithic, antiespamodic, pain-relieving or any other property related to the urinary wellness.

Pharmactive Biotech Products

Details of the Innovation Need

The company is seeking an innovative botanic extracts to be used alone or in combination with our proprietary herbal extracts.

The call is open to offers of botanic/herbal extracts ready to be used in the main World Markets and, therefore, from plants and technologies acceptable by the concerning Food or Pharma Authorities from Europe, United States, Canada, Australia/New Zealand, Japan, China, Korea, Brasil and other critical countries.

The intended use of the extract does not include prescription drugs.

The offer ideally will include convincing evidence (published human clinical trials are highly desirable) on any aspect related to urinary health and wellness without counter-indications with drugs and other phytotherapeutic products.

The extract must be compatible with oral administration.

Extracts produced industrially or at pilot plant level are preferred. The use of innovative and green production processes would be a plus.

The company offers: trade or licensing agreements.

Discarted solutions

  • Not food/pharma grade extracts
  • Well-known extracts in the market without innovative sources, properties, apl¡plications.
  • Unable to the be used orally

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Medical Research
  • Virus, Virology / Antibiotics / Bacteriology
  • Industrial Biotechnology
  • Agrofood Industry
  • Technologies for the food industry
  • Food Additives/Ingredients/Functional Food
  • Medical Health related
  • Therapeutic
  • Other Medical/Health Related

About Pharmactive Biotech Products

European plant extracts manufacturer. The company invests more than 10.00% of its turnover to R&D activities

Alberto Espinel

Never miss an update from Alberto Espinel

Create your free account to connect with Alberto Espinel and thousands of other innovative organizations and professionals worldwide

About Innovation Needs

Innovation Needs on Innoget are directly posted and managed by its members as well as evaluation of proposals. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help submitting your proposal or have questions regarding this Innovation Need?
Contact Innoget support

FAQs

In the solution proposal submission form:

  • Do not disclose confidential information that is not properly protected
  • Explain and focus on the benefits of applying and/ or developing your solution or technology rather than how you will get into it
  • Provide information about specific expected outcome, implementation or developing timeline and costs
  • Explain about your track record on projects you have successfully worked related to this technology field
  • Use pre-defined buttons to give specific details about your proposal “Stage of development”, “Commercial Information” and “Intellectual Property Status”
The posting organization will directly evaluate your proposal. Please avoid sending spam as you can be blocked by posting members.
You are not asked to reveal any confidential information nor provide any solution that is not protected at this point. You just have to provide non-confidential information. After submitting your proposal, the posting company will evaluate it and directly connect with you. This is when if there is an interest you would request to sign an NDA with the company to keep the conversation ongoing.
Never reveal Confidential Information that it is not properly protected.
There is no need to sign an NDA. You are not asked to reveal any confidential information nor provide any solution that is not protected at this point. You just have to provide non-confidential information. After submitting your proposal the posting company will evaluate it and directly connect with you. This is when if there is an interest you would request to sign a Non-Disclosure Agreement (NDA) with the company to keep the conversation ongoing.
The average response rate for this user is 3 weeks
The posting company will directly contact you to open up discussions about your proposal and potential collaboration opportunities
You will be notified and provided with feedback from the posting company. You can always transform your proposal into a Technology Offer to present it to other members at no cost